A multicenter phase II study on the efficacy and safety of hetrombopag in patients with severe aplastic anemia refractory to immunosuppressive therapy.

Guangxin PengGuang-Sheng HeHong ChangSujun GaoXinjian LiuTong ChenPei LiBing HanMiao MiaoZheng GeXiaoyan GeFei LiYingmei LiShunqing WangYi WangYaqi ShenTao ZhangJianjun ZouFengkui Zhang

Published in: Therapeutic advances in hematology (2022)

NCT03557099.

Keyphrases

phase ii study
open label
locally advanced
chronic kidney disease
early onset
allogeneic hematopoietic stem cell transplantation
iron deficiency
cross sectional
squamous cell carcinoma
clinical trial
double blind
randomized controlled trial
mesenchymal stem cells
cell therapy
bone marrow
replacement therapy